Dose-escalated simultaneous integrated boost radiotherapy may increase ipsilateral breast tumor relapse rates
1. 5-year ipsilateral breast tumor relapse rates for test group 1 were non-inferior to the control group. However, noninferiority was ...
1. 5-year ipsilateral breast tumor relapse rates for test group 1 were non-inferior to the control group. However, noninferiority was ...
Click to read this study in the European Journal of Cancer.
Click to read the study in the European Journal of Cancer.
1. Intensity-modulated proton therapy was associated with fewer adverse events than intensity-modulated radiation therapy in the treatment of patients with ...
Click to read the study in Lancet Oncology.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.